0001104659-22-088896.txt : 20220810 0001104659-22-088896.hdr.sgml : 20220810 20220810212343 ACCESSION NUMBER: 0001104659-22-088896 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220808 FILED AS OF DATE: 20220810 DATE AS OF CHANGE: 20220810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wicki Andreas CENTRAL INDEX KEY: 0001511472 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 221153404 MAIL ADDRESS: STREET 1: C/O HBM BIOVENTURES (CAYMAN) LTD. STREET 2: CENTENNIAL TOWERS,STE.305,2454 W.BAY RD. CITY: GRAND CAYMAN STATE: E9 ZIP: E9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 tm2222520-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-08 0 0001802665 Harmony Biosciences Holdings, Inc. HRMY 0001511472 Wicki Andreas GOVERNORS SQUARE, 23 LIME TREE BAY AVE., PO BOX 30852 GRAND CAYMAN E9 00000 CAYMAN ISLANDS 1 0 0 0 Common Stock 2022-08-08 4 S 0 486360 53.94 D 3104282 I See Footnote Common Stock 2022-08-09 4 S 0 20745 53.67 D 3083537 I See Footnote Common Stock 2022-08-10 4 S 0 71447 52.61 D 3012090 I See Footnote The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.55 to $54.94, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote one (1) of this Form 4. These shares are held by HBM Healthcare Investments (Cayman) Ltd. ("HBM"), of which Mr. Wicki is a member of the board of directors. The board of directors of HBM acts by majority vote, and Mr. Wicki does not have sole voting or investment power with respect to the shares. Mr. Wicki disclaims beneficial ownership of such shares for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.50 to $54.11, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.51 to $52.865, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote four (4) of this Form 4. /s/ Mehdi Khodadad, Attorney-in-fact 2022-08-10